2021/2601(DEA)
Inclusion of the new psychoactive substances methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) and methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) in the definition of ‘drug’
Basic information
2021/2601(DEA)
DEA - Delegated acts procedure
Subject
4.20.03 Drug addiction, alcoholism, smoking
7.30.30.04 Action to combat drugs and drug-trafficking
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 12/03/2021 | Non-legislative basic document published | C(2021)01570 | |
| 12/03/2021 | Initial period for examining delegated act 2 month(s) | ||
| 24/03/2021 | Committee referral announced in Parliament | ||
| 22/05/2021 | Delegated act not objected by Parliament |
Technical information
| Procedure reference | 2021/2601(DEA) |
|---|---|
| Procedure type | DEA - Delegated acts procedure |
| Procedure subtype | Examination of delegated act |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
LIBE/9/05608
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2021)01570 12/03/2021